The Expanding Role of MRI in Prostate Cancer: Self-Assessment Module is organized by American Roentgen Ray Society (ARRS).
Date of issuance: November 22, 2013
Date of expiration: November 21, 2019
Estimated time to complete the activity: 1 hour(s)
The target audience for this activity is readers of the AJR, radiologists, radiologists-in-training, and other health professionals with an interest in the clinical applications of MRI to the diagnosis and management of prostate cancer.
The ARRS designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credit(s)™.
This activity meets the ABR's criteria for a self-assessment activity in the ABR Maintenance of Certification program. The ARRS has been granted SAM Deemed Status by the American Board of Radiology (ABR). This allows the ARRS to develop and implement, without prior ABR review, enduring SAMs that satisfy ABR Part II MOC requirements. The modules designated as SAMs qualify as self-assessment modules and meet the ABR SAM requirements. 1.00 SAM credit will be given in the ABR category C04 Genitourinary for completion of this activity.
Goals and Objectives:
After completing the material in this article, the learner should be able to:
• Describe the current role of MRI in the diagnosis and management of prostate cancer; and
• Delineate the imaging features of prostate cancer on MRI.